Revive Therapeutics Ltd.
RVVTF
$0.02
$0.007.53%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.68M | -7.71M | -7.80M | -7.95M | -2.90M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 100.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.11M | 7.02M | 7.03M | 6.97M | 1.78M |
| Change in Net Operating Assets | 455.20K | 526.90K | 462.50K | 424.10K | 368.70K |
| Cash from Operations | -113.70K | -165.10K | -314.70K | -555.90K | -753.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | -22.00K | 7.20K |
| Cash from Investing | 0.00 | 0.00 | 0.00 | -22.00K | 7.20K |
| Total Debt Issued | 0.00 | 65.00K | 65.00K | 65.00K | 65.00K |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -25.80K | -104.60K |
| Issuance of Common Stock | 148.80K | 148.80K | 148.80K | -- | 84.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -25.80K | -25.80K | -25.80K | 0.00 | -19.50K |
| Cash from Financing | 89.30K | 134.60K | 134.60K | 26.60K | 16.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.40K | -30.50K | -180.10K | -551.30K | -730.20K |